Seno Medical Instruments
About Seno Medical Instruments
Seno Medical Instruments is a medical imaging company focused on commercializing opto-acoustic (photoacoustic) imaging, a novel modality for cancer diagnosis. Their flagship product, the Imagio® Breast Imaging System, integrates opto-acoustic technology with conventional ultrasound to provide real-time functional and anatomical images of the breast. This system aims to enhance diagnostic confidence by detecting angiogenesis (new blood vessel growth) and deoxygenation, which are key physiological indicators of malignancy, thereby potentially reducing the rate of unnecessary breast biopsies.
The Imagio® system, which received FDA PMA approval in 2021 (with supplemental approval in 2022) and CE Mark certification under MDR in January 2026, offers a non-invasive approach that does not expose patients to ionizing radiation or contrast agents. It also incorporates AI-based decision support (SenoGram®) to further assist clinicians in differentiating between benign and malignant breast lesions. Beyond breast cancer, Seno Medical’s patented platform technology holds potential for future applications in the early detection and diagnosis of other cancers, including melanoma, thyroid, prostate, colon, head and neck, cervical, ovarian, and bladder cancer, as well as for therapeutic monitoring.
Focus Areas
Business Intelligence
| Key Investors | MedCare Investment Funds, Texas Emerging Technology Fund, WP Global Partners |
| Partnerships | VisualSonics (2008), University of Prince Edward Island (2008), Ryerson University of Toronto (2008), Vizient (November 2024), IHE SHARAZONE (May 2024), Pinnacle Health Group (February 2024) |
| Acquisitions | Acquired early opto-acoustic technology and working pre-prototypes from Dr. Alexander Oraevsky and Fairway Medical Technologies in exchange for stock (2005) |
| Technology | Opto-acoustic imaging (photoacoustic imaging or PAI) fused with ultrasound (OA/US), laser and acoustics integration, functional imaging, AI-based decision support (SenoGram®) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Seno Medical Instruments' Imagiou00ae system offers a significant advancement for physicians by providing real-time, functional diagnostic imaging that can increase diagnostic confidence and reduce unnecessary biopsies. The fusion of opto-acoustics with ultrasound, coupled with AI-driven decision support (SenoGramu00ae), allows for a more precise differentiation between benign and malignant breast tissue without ionizing radiation, injected contrast agents, or compression. This leads to a simplified diagnostic pathway, faster answers for patients, and improved workflow efficiency for practices. The ability to visualize angiogenesis and deoxygenation provides critical functional information that traditional anatomical imaging modalities cannot. Furthermore, clinical data suggests the system may help differentiate prognostic subtypes of breast cancer, potentially aiding in tailored treatment regimens.
The Imagiou00ae Breast Imaging System is a hybrid modality device that concurrently collects opto-acoustic images in conjunction with diagnostic gray-scale (B-mode) ultrasound. Its native AI clinical decision support tool, SenoGramu00ae, is purpose-built to work seamlessly with the system, providing integrated diagnostic assistance. While specific integrations with broader PACS or EMR systems are not detailed, the system's ability to provide real-time functional and anatomical images, along with AI-driven insights, suggests a design aimed at streamlining the diagnostic workflow within existing clinical environments.
What the Web Says
Seno Medical Instruments, Inc. is a medical device company focused on developing opto-acoustic technology for breast cancer diagnosis. While specific product reviews are limited on major platforms, employer reviews on Glassdoor indicate a generally positive work environment with some common challenges seen in smaller companies. The company's technology, Imagiou00ae, has received FDA approval and is designed to improve diagnostic accuracy.
Overall: MixedStrengths
- Innovative technology (Imagiou00ae) for breast cancer detection
- Positive impact on patient care
- Good work-life balance reported by some employees
- Supportive colleagues and management in many instances
- Opportunity to work with cutting-edge medical technology
- FDA approval for their key product
Limitations
- Limited public product reviews on major platforms (G2, Capterra)
- Compensation can be a concern for some employees
- Challenges with company growth and scaling processes
- Potential for long hours in certain roles
- Communication issues reported by a minority of employees
- Small company environment may not suit everyone
Based on reviews from: Glassdoor, Seno Medical Website, Healthcare IT News/Press Releases (regarding FDA approval)
Last updated: 2026-07-19
Videos
News, demos, and interviews about Seno Medical Instruments.
Videos load interactively. If none appear, search YouTube for Seno Medical Instruments →
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]